Cell Line Genetics (CLG) was founded to address the growing need for products and services to support researchers and companies in the Embryonic Stem Cell and Cancer Research market.

CLG provides end-to-end quality assurance, including characterization (Karyotyping, FISH, M-FISH), authentication (DNA Fingerprinting), genotyping and custom products and services focusing on multi-species ES Cell and Cancer Cell Lines. CLG also performs FISH-based Clinical Cancer Testing, using the Abbott/Vysis™ line of products.

Our quicker turnaround and expertise in ES and Cancer Cell Lines will help accelerate your project lifecycle, significantly lowering research costs and saving substantial researcher-hours.